Rank #1440PCRX

Pacira BioSciences, Inc.

$23.18

0.70% (Daily)

Market Cap

$997.23M

Revenue

$716.79M

Rank by MCap

#1440

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Frank D. Lee

Headquarters

Brisbane, CA

Employees

788

About Pacira BioSciences, Inc.

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handhel...